chrisvoncsefalvay/vaers-outcomes huggingface dataset:
~10 minutes after in-home vaccine administration, patient complained of significant localized itching of lower aspects of feet bilaterally, causing anxiety, some mild tachypnea (RR ~20), and mild tachycardia (HR ~110, regular). No other symptoms, including absence of upper airway problems, dermal reactions, or evidence of hypo perfusion but in significant discomfort (patient rated 10/10). Due to obesity & long fingernails, pulse ox & BP were not detectable. Following some deep breathing exercises, anxiety and tachycardia improved and patient given diphenhydramine 25mg po x 1 ~2:35pm. Symptoms improved (rated 5/10) at 2:50pm, HR ~100 (regular), RR normal. 3:15pm: itching much improved (2/10), patient ambulated to couch without incident. 3:30pm: symptoms mostly gone, patient much more comfortable. 4:15pm: symptoms resolved.
severe local rxn;lt arm swollen size grapefruit;seen by PMD x2 for eval;blood work done;PMD reports rxn to pertussis;hosp reports pt lt arm red & swollen ? early cellulitis, tender, indurated, bruised;cold sx-nasal congestion-cough-rhinitis
Pt had JEV (right) and typhoid (left) afternoon of 9/12/08.  Pt had a cold (productive cough, sneezing).  9/14/08 pt felt chilled although he was sweating; did not take temp; took tylenol; cough was worse.  9/16/08 0130 pt woke with sensation of burning/intense itching of legs.  He had flesh colored raised areas up to 3" all over legs and feet (worse behind knees); itchy eyes and increased rhinnorhea; no SOB or scratchy throat.  Pt sprayed his legs with generic athletes foot spray which did not help.  Rash  was better in the arm and resolved by noon.  No recent outdoor activity, no new soap, detergent, clothes, linens.  No other people in barracks with rash.
Dry Cough; Chills; bone and joint pain in hip and shoulder area; bone and joint pain in hip and shoulder area; Fatigue; Headache; Chest heaviness; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Chest heaviness), COUGH (Dry Cough), CHILLS (Chills), BONE PAIN (bone and joint pain in hip and shoulder area) and ARTHRALGIA (bone and joint pain in hip and shoulder area) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No adverse event).    On 04-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced CHEST DISCOMFORT (Chest heaviness), CHILLS (Chills), BONE PAIN (bone and joint pain in hip and shoulder area), ARTHRALGIA (bone and joint pain in hip and shoulder area), FATIGUE (Fatigue) and HEADACHE (Headache). On 07-Jan-2021, the patient experienced COUGH (Dry Cough). At the time of the report, CHEST DISCOMFORT (Chest heaviness), COUGH (Dry Cough), CHILLS (Chills), BONE PAIN (bone and joint pain in hip and shoulder area), ARTHRALGIA (bone and joint pain in hip and shoulder area), FATIGUE (Fatigue) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This spontaneous report as received from a licensed practical nurse refers to a 1 or 2 unspecified patients of unknown age and gender. On an unknown date, the patient was vaccinated with a dose of improperly stored PROQUAD (Merck) (route and dose were not reported) (lot # L030587, expiration date: 10-FEB-2017). The PROQUAD was stored in -10 Celsius degrees for 12 hours. There was no previous temperature excursion and the call as because of a data logger. This is one of two reports received from the same source. Additional information has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025b21a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ASCORBIC ACID (VIT C), THIAMINE (VITAMIN B1 [THIAMINE]), COLECALCIFEROL (VIT D3), FOLIC ACID and MAGNESIUM for an unknown indication.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In September 2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication also include 2 medicine for intestine. No treatment medications were provided.  Patient mentioned he was experiencing flu like symptoms may be because of change of weather.  As the company fired all the employees because of lack of work patient didn't receive the 2nd dose of the Moderna COVID19 vaccine
pt had MMR 6APR92 & devel mumps MAY92; 8JUL92 mom says can't remember exact details but pt had node on lt side of neck; red & tender;
Shots were given 8/11/04.  Two hours later, the baby began to be very fussy but consolable.  The next day (8/13/04) the baby was very fussy in periods of inconsolable crying.  Temp was 100.7 after a tylenol dose.  Baby only took 4 oz of formula when I saw baby.  Baby had a normal exam and was fussy and difficult to console.  I flouresceined her eyes and that was normal.  I gave the baby pedialyte and she took a couple ozs. Baby calmed down.  I sent the baby home and called later.  The baby had taken 8 oz of pedialyte and was doing better.  I called again on 8/16/04 and the baby was reported to have some fussy times on 8/14 and one spell on 8/15 but seemed better this morning.
20SEP95 820 phone call from father 8 hrs p/vax pt became febrile @ 103 ax, 10mins later 101 ax-no local redness or edema @ inj site-alert-fussy; no high pitched cry-no sz activity;given Motrin susp-seen by MD
MOC reports child broke out in chicken pox rash 2 days after immunization given.
Woke @ 4am w swollen lips.tht felt like a thousand needles poking cheeks and eyeballs tht felt very hard and tender...cheeks and eyeballs resolved p app 8hrs but lips remained swollen several days.
Had much side effects like she did; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (Had much side effects like she did) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced ADVERSE DRUG REACTION (Had much side effects like she did). At the time of the report, ADVERSE DRUG REACTION (Had much side effects like she did) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Pt given PROQUAD instead of MMR vaccine: MMR ordered at time of visit.
Fever of 99.1, along with full body muscle aches on 4 June, treated with 800mg of  ibuprofen.  Fever of 99.6 along with some muscle aches in arms and legs on 5 June, treated with 800 mg of ibuprofen. Intermittent muscle spasms in arm/shoulder near injection, started early morning of 7 June, has not stopped yet (been 10 hours since it began)
While administering a flu vaccine to the employee, the pre-filled syringe malfunctioned and the vaccine came out around the needle at the hub. The needle felt like it was stripped. The flu ambassador had to administer a second flu vaccine to the employee.
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Allergic: Rash Generalized-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Unable to Sleep-Severe, Additional Details: unsual discomfort
pt recv vax 13MAY97 & on 15MAY97 pt exp severe upper resp infect & non varicella-like rash on trunk & arms;
Oct 1, 2015 at noon - flu vaccine. For 1 1/2 days one side of throat swelled, and cheek swelled like a golf ball, lower back pain - kidneys. I never have lower back pain. This all started 26 hrs after vaccine. I took 2 loratadine (antihistamine pills). I am still concerned for kidneys if permanent.
The pt died from sudden infant death syndrome on 1/6/01 within 18 hours of vaccine administration.
anxiety related reaction- heart palpitations, feeling of passing out. Now taking anti anxiety and anti depression medications in result  of reaction also seeing a therapist.
malaise; covid arm; low grade fever/low grade temperature/normal temperature is 97.8, on sunday he recorded 100.2; body aches; (arm) swollen; (arm) it had redness; headache; chills; joint pain; pain that night/still sore to the touch; itch; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (malaise), VACCINATION SITE REACTION (covid arm), PAIN (pain that night/still sore to the touch), PRURITUS (itch) and PERIPHERAL SWELLING ((arm) swollen) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058E21A, 003AZ1A and 030L(Z)0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METOPROLOL, TIMOLOL and CYANOCOBALAMIN (B12 [CYANOCOBALAMIN]) for an unknown indication.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Sep-2021, the patient experienced PAIN (pain that night/still sore to the touch) and PRURITUS (itch). On 12-Sep-2021, the patient experienced PERIPHERAL SWELLING ((arm) swollen), ERYTHEMA ((arm) it had redness), HEADACHE (headache), CHILLS (chills) and ARTHRALGIA (joint pain). On an unknown date, the patient experienced MALAISE (malaise), VACCINATION SITE REACTION (covid arm), PYREXIA (low grade fever/low grade temperature/normal temperature is 97.8, on sunday he recorded 100.2) and MYALGIA (body aches). At the time of the report, MALAISE (malaise), VACCINATION SITE REACTION (covid arm), PAIN (pain that night/still sore to the touch), PRURITUS (itch), PERIPHERAL SWELLING ((arm) swollen), ERYTHEMA ((arm) it had redness), PYREXIA (low grade fever/low grade temperature/normal temperature is 97.8, on sunday he recorded 100.2), HEADACHE (headache), CHILLS (chills), ARTHRALGIA (joint pain) and MYALGIA (body aches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication was provided.  Patient was taking vitamins and supplements.   Patient received the 3rd dose. It was not clarified if the caller was immunocompromised or not.
MMR vaccine expired on 6/16/2022 and was administered on 6/20/2022.  Contacted health department and heard from nurse who advised the following:  "when an expired medication is given to patient, the dose needs to be repeated.  Since this was a live vaccine, you should wait at least 4 weeks (28 days) after the previous (expired) dose was given before repeating it.  Although simply repeating dose is preferred, serological testing to check for immunity may be accepted."  Parent of patient has been called and voice mail left requesting they contact clinic to discuss the above information.
Fever up to 100.2, pain, itchiness at site, arm feels heavy, pressure on arm, then pain all over body few days later. Doctor prescribed hydroxyzine and triamcinolone and OTC Tylenol.
After the vaccine was given to my son, the location the vaccine was given swelled up the size of a baseball, it was not just slight swelling. I had my child ice the location and gave him a bath in epsom salts to help to detox his body from the antigens in the vaccine. My son could hardly move his arm and it was very sore. On the second day I called the Health Department and my sons physicians office to report the adverse event although the swelling had gone down slightly, was still sore and was extremely itchy. I made my son a baking soda paste to help relieve the itching, gave him an additional epsom salt bath and had him ice the location again to bring down the swelling. By the end of the second day the swelling went down but his arm was still rather sore.
all body tingling, foggy mind, unable to fully focus eyes, SOB and pain in lungs. Gave benadryl 25mg. and monitored. Resolved 70 minutes following start.
Hard to swallow at around 5 pm, eyes starting to get droopy, completely exhausted. Next two days, symptoms resolved. Absence of fever.
Initial report received from a healthcare professional on 27 August 2013. A female patient whose date of birth and age at the time of event was not reported, had received a dose of YF VAX vaccine (lot number, dose in series, route and site of administration was not reported) on 25 June 2013. The patient had medical history of asthma and concomitant medications were not reported. On 27 June 2013, the patient developed URI (upper respiratory infections) symptoms and body ache. It was reported that the patient had low grade temperature. Laboratory investigations and corrective treatments were not reported. At the time of this report the outcome of the event was unknown. Documents held by sender: none.
Wheezing, collapsed w/in 10 minutes of receiving 2nd dose; Taken to ER in anaphylactic shock & recovered;
joint pain; tiredness; weakness; chill/chilly; This is a spontaneous report from a contactable consumer(patient). A 37-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE,Solution for injection), via an unspecified route of administration, administered in Arm Left on 17Apr2021 at 11:45 a.m (At the age of 37-year-old) (Batch/Lot Number: EW0161) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. No Prior Vaccinations taken within 4 weeks. The patient wanted to know that if he had a side effect after the first dose of the vaccine, Should he get the second dose. As noted in the Fact Sheet for Recipients, you should not get the Pfizer-BioNTech COVID-19 Vaccine if you had a severe allergic reaction after a previous dose of the vaccine or if you had a severe allergic reaction to any ingredient of the vaccine. The decision to receive the second dose for any other reason cannot be made by Pfizer. We refer you to speak to your healthcare provider about the risks of the vaccine compared to the risks of potentially not being fully protected against COVID-19 infection. Your healthcare provider knows your health situation and has access to information that can better help inform this decision, States he doesn't have a fever and he took Panadol, states it is like acetaminophen. Caller is unable to confirm spelling of product. States he just has those 2 things, weakness and chilly. He wanted to know if these are commonly reported side effects of getting the vaccine. He wanted to know if he can take paracetamol/Tylenol following the side effects that he is experiencing. On 18Apr2021 the patient experienced joint pain, tiredness, weakness, chill/chilly. The outcome of the event joint pain was unknown, tiredness, weakness, chill/chilly was recovering.  E-transmitting as potential AE duplicate.  PSCC Communication: Referred caller to contact his healthcare provider for medical advice. Provided caller with Medical Information phone number and hours of operation. Attempted a warm transfer to medical information, no agent was reached. Caller opted to be placed in hold queue.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Fever to 104F (ear) 3 hours, post vax, associated with chills. Spiked fever X 3 with 3 episodes of emesis. Alternating irritability and lethargy. Treated with antipyretics and close observation.
No additional AE; Caller reported that M-M-R II, ROTATEQ and VAQTA that underwent temperature excursions were administered. No further information was provided. No additional AE. No PQC.   ?    Names of vaccines involved (including lot/exp): M-M-R II LOT: T029550 EX; This spontaneous report was received from Pharmacist and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.   On 27-MAY-2022, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, lot #T029550, expiration date: 01-SEP-2022, administered for prophylaxis (strength, dose, anatomical location and route of administration were not provided).  The vaccine was stored at the temperature that was reported as above 46 degrees of Fahrenheit (46.9 F) for 25 minutes. There was a previous temperature excursion reported: above 46 degrees of Fahrenheit (47.2 F) for 25 minutes.  No additional adverse event was reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2206USA005639: US-009507513-2206USA005640: US-009507513-2206USA006600: US-009507513-2206USA006599: US-009507513-2206USA006597: US-009507513-2206USA006596: US-009507513-2206USA006598:
This spontaneous case reported by a consumer, describes the occurrence of contusion (bruise) and intermenstrual bleeding (menstrual spotting) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 001821A and 001B21A) for COVID-19 immunization. Concurrent medical conditions included arthritis and drug allergy (Aspirin). Concomitant products included vitamins (NOS) for an unknown indication. Other concomitant medication included medication for arthritis. On Feb 24, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), unknown route; 1 dosage form. On Mar 24, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 24, 2021, patient experienced contusion (bruise) and intermenstrual bleeding (menstrual spotting). At the time of the report, contusion (bruise) and intermenstrual bleeding (menstrual spotting) outcome: unknown. Action taken with mRNA-1273 (Moderna COVID-19 vaccine) in response to the event: not applicable.
Information has been received from a pharmacist concerning a 70-80 year old male with diabetes and a history of a total knee replacement (June 2003) who in October 2004, (date not specified), was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (Lot # unknown). In November 2004 (date not specified), the patient developed an infection of the same knee and was hospitalized. The culture showed pneumococcus infection (specific organism not known). It was reported that the patient was treated with antibiotics and released from the hospital after an unknown length of stay. There was no product quality complaint involved. Additional information has been requested.
Accidental overdose; bad taste in his mouth, almost a bitterness; COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), DYSGEUSIA (bad taste in his mouth, almost a bitterness) and ACCIDENTAL OVERDOSE (Accidental overdose) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) tablet for COVID-19 treatment.    No Medical History information was reported.   On 19-Apr-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (Oral) morning 3 DF, evening On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form, third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2022, the patient experienced COVID-19 (COVID-19). On 19-Apr-2022, the patient experienced DYSGEUSIA (bad taste in his mouth, almost a bitterness). On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (Accidental overdose). At the time of the report, COVID-19 (COVID-19) and ACCIDENTAL OVERDOSE (Accidental overdose) outcome was unknown and DYSGEUSIA (bad taste in his mouth, almost a bitterness) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Apr-2022, SARS-CoV-2 test: (Positive) Positive.         No information on concomitant medication were reported. Patient were double boosted with Covid vaccines. Stated he had four doses of Moderna vaccines. No treatment details were reported. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
EMS evaluated patient after he reported dizziness, chest pains, sweating, and chills. His blood pressure was taken and recorded as 66/39, then 85/55, then 127/55.
Vaccine expired at time of administration. Expiration date 11/30/2022. No adverse reaction. Repeat dose with unexpired vaccine pending receipt of product.
2nd dose of the Moderna COVID-19 bivalent vaccine was administered to a patient in error; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXTRA DOSE ADMINISTERED (2nd dose of the Moderna COVID-19 bivalent vaccine was administered to a patient in error) and NO ADVERSE EVENT (No adverse event) in an adult male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.  On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (2nd dose of the Moderna COVID-19 bivalent vaccine was administered to a patient in error) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXTRA DOSE ADMINISTERED (2nd dose of the Moderna COVID-19 bivalent vaccine was administered to a patient in error) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXTRA DOSE ADMINISTERED (2nd dose of the Moderna COVID-19 bivalent vaccine was administered to a patient in error).    No concomitant medications were reported.  The patient had not reported any adverse reactions at this time.   The healthcare professional (HCP) was calling to see if there are any unique side effects associated with the administration of a 2nd bivalent booster dose of the Moderna COVID-19 vaccine.  No treatment medications were reported.
This is my 1st Pfizer shot. My other 2 were Moderna, 3rd shot as a booster left back of arm. Left arm started to get sore about 10 hours in, persisted until the following day when I notice a lump in my armpit the size of a soft ball. It's huge! I noticed this about 27 hours after the booster vaccine.
Leg pain and arm pain, groin, butt, tingling in mouth, tingling in feet, hand tremors. All of this occurs 24hr a day.